AAN recommendations on natalizumab in MS


The American Academy of Neurology has issued its recommendations on the use of natalizumab in the treatment of multiple sclerosis (Goodin et al. Neurology 2008;71:766-773).

The recommendations were based on an expert panel review of six randomized controlled trials.

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page